Myeloperoxidase-specific anti-neutrophil cytoplasmic autoantibodies - Related scleroderma renal crisis treated with double-filtration plasmapheresis

32Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

A 46-year-old female patient who was diagnosed with systemic sclerosis (SSc) developed rapidly progressive renal failure without elevation of blood pressure or plasma renin concentration. Renal biopsy revealed necrotizing crescentic glomerulonephritis (pauci-immune type) and the myeloperoxidase- specific anti-neutrophil cytoplasmic autoantibodies (MPO-ANCA) titer was found to be elevated to 669 EU/ml. Methylprednisolone (MP) pulse therapy followed by prednisolone (PSL) and mizoribine (MZR) did not suppress the progression of renal failure. Therefore, we started double-filtration plasmapheresis (DFPP) which effectively removed MPO-ANCA and prevented renal failure despite the relatively low dose of immunosuppressive agents.

Cite

CITATION STYLE

APA

Omote, A., Muramatsu, M., Sugimoto, Y., Hosono, S., Murakami, R., Tanaka, H., … Kato, K. (1997). Myeloperoxidase-specific anti-neutrophil cytoplasmic autoantibodies - Related scleroderma renal crisis treated with double-filtration plasmapheresis. Internal Medicine, 36(7), 508–513. https://doi.org/10.2169/internalmedicine.36.508

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free